Ascentage Pharma Group International (AAPG) income statement
AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$12.44−0.57 (-4.40%)
Close on Nov 19, 2026Market cap $1.16BP/E –Yield –
Ascentage Pharma Group International income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 91.5%
- Operating margin
- –
- Net margin
- -216.5%
- Return on equity, FY2025
- -156.5%
Financial strength
- Current ratio
- 1.79
- Debt to equity
- 1.50
- Debt to assets
- –
- Cash to current liabilities
- 72.8%
Valuation
- P/E ratio
- –
- Price to sales
- 13.49
- Price to book
- 5.85
- Dividend yield
- –
See a number that looks wrong?